Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bicrome
- Development stage
- Unknown
- Lead developer
- NVP Healthcare
- Modality
- Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
01
Overview
Bicrome is a commercial brand of functional probiotics developed by NVP Healthcare (Navipharm) that utilizes proprietary "two-strain complexes" of lactic acid bacteria to target specific health indications via the gut-organ axes. The product line includes formulations for nasal health (NVP-1703, containing *Lactobacillus plantarum* IM76 and *Bifidobacterium longum* IM55), liver health (NVP-1702, containing *L. plantarum* LC27 and *B. longum* LC67), and brain health (NVP-1704). These probiotics function by modulating the gut microbiome, which in turn regulates systemic immune responses and inflammatory pathways. For example, the nasal health variant is clinically recognized in South Korea for its ability to improve symptoms of perennial allergic rhinitis by balancing Th1/Th2 immune responses and reducing inflammatory cytokines.
- Brand names
- Bicrome
- Other names
- Bicrome Nasal HealthBicrome Liver HealthBicrome Brain Health
Beyond the preview
Go deeper on Bicrome.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Bicrome.